C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji(Johns Hopkins University), Theodoros Karantanos(Johns Hopkins University), Linda Resar(Johns Hopkins University), Pablo Toledano-Sanz(Johns Hopkins University), Alexander J. Ambinder(Johns Hopkins University), Amy E. DeZern(Johns Hopkins University), Sergiu Paşca, Richard J. Jones(Sidney Kimmel Comprehensive Cancer Center), Ilias Sinanidis(Johns Hopkins University), Brandy Perkins(Johns Hopkins University), Ivana Gojo(Johns Hopkins University), Bogdan C. Paun(Johns Hopkins University), Theodora Chatzilygeroudi(Johns Hopkins University), Suman Paul(Johns Hopkins University), Christopher Esteb(Johns Hopkins University), Leo Luznik(Johns Hopkins University), Joseph Rimando(Emory University), Lukasz P. Gondek(Johns Hopkins University), Chen Lossos(Johns Hopkins University), Priyanka Fernandes(Johns Hopkins University), Panagiotis Tsakiroglou(Johns Hopkins University), Yoon‐Kyo An(Mater Hospital), C. Conover Talbot(Johns Hopkins University), Rena R. Xian(Johns Hopkins University), Mark J. Levis(Sidney Kimmel Cancer Center), Styliani Karanika(Johns Hopkins University), Xinghan Zeng(Johns Hopkins University), Frederick Bunz(Johns Hopkins University), Abdulmuez Abdulmalik(Johns Hopkins University), Tatianna R. Boronina(Johns Hopkins University), Marios Arvanitis(Johns Hopkins University), Yashvi Hemani, Robert N. Cole(Johns Hopkins University)
Cited by 2
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
|Oncogene|2013|879
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
|Nature|2012|745